89bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023 at 04:53 pm EDT
89bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 38.39 million compared to USD 25.05 million a year ago. Basic loss per share from continuing operations was USD 0.52 compared to USD 1.23 a year ago.
For the six months, net loss was USD 67.23 million compared to USD 50.62 million a year ago. Basic loss per share from continuing operations was USD 1.06 compared to USD 2.49 a year ago.